Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 23, 2025 07:03 ET | Source: Novonesis (Novozymes A/S)

Noma and Novonesis partner to scale deliciousness

Noma and Novonesis partner to scale deliciousnessNoma, hailed as one of the world’s best restaurants, is joining forces with Novonesis, the global leader in biosolutions, to take deliciousness to the...
September 08, 2025 02:43 ET | Source: Novonesis (Novozymes A/S)

Novonesis and Novo Nordisk will explore new solutions to improve metabolic health

Novonesis and Novo Nordisk join forces in a new research collaboration to explore solutions that seek to preserve and optimize metabolic health and well-being for people. COPENHAGEN,...
August 21, 2025 02:03 ET | Source: Novonesis (Novozymes A/S)

Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%

COPENHAGEN, Denmark – August 21, 2025. Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%. Ester Baiget, President & CEO: “I’m very pleased with 9%...
August 20, 2025 13:35 ET | Source: Novonesis (Novozymes A/S)

2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement

COPENHAGEN, Denmark - August 20, 2025. Novonesis today announces its ‘GROW’ strategy and long-term targets for the strategy period until 2030 focusing on an acceleration of the core business and...
July 30, 2025 16:02 ET | Source: Dyadic International, Inc.

Dyadic International, Inc. Announces Proposed Public Offering of Common Stock

Dyadic International, Inc. Announces Proposed Public Offering of Common Stock
July 07, 2025 02:33 ET | Source: Novonesis (Novozymes A/S)

Biosolutions could create more than 600,000 jobs and unlock hundreds of billions in growth for Europe

Biosolutions could create more than 600,000 jobs and unlock hundreds of billions in growth for Europe A new report reveals that biosolutions could generate EUR 133 billion in economic gains...
May 08, 2025 02:00 ET | Source: Novonesis (Novozymes A/S)

Novonesis delivered a strong Q1 with 11% organic growth and confirms full-year outlook

COPENHAGEN, Denmark – May 8, 2025. The global leader in biosolutions, Novonesis, had a strong start to its financial year with organic sales growth of 11% and an adjusted EBITDA margin of 38.3%. The...
February 26, 2025 02:04 ET | Source: Novonesis (Novozymes A/S)

12M 2024: Novonesis delivers strong full-year results and expects continued growth in 2025

Novonesis delivers 8% organic sales growth with an adjusted EBITDA margin of 36.1% in 2024. For 2025, Novonesis presents an outlook of 5-8% organic sales growth with an adjusted EBITDA margin of...
February 11, 2025 01:13 ET | Source: Novonesis (Novozymes A/S)

Novonesis to acquire dsm-firmenich’s share of the Feed Enzyme Alliance

Novonesis has reached an agreement with dsm-firmenich to dissolve the Feed Enzyme Alliance and take over its sales and distribution activities, in exchange for a total cash consideration of EUR 1.5...
November 07, 2024 02:02 ET | Source: Novonesis (Novozymes A/S)

Q3 update: Novonesis delivers strong Q3 results and now expects full-year organic sales growth at the upper end of 7-8%

Following increasing demand in the first nine months of the 2024 financial year, Novonesis delivers 9% organic sales growth with a strong 11% organic sales growth in the third quarter. The strong...